top of page



12:00 p.m. - 2:00 p.m.


The Science & Innovation Symposium is part of the in-person event held at Staglin Family Vineyard and melds the expertise of its guest speakers with its welcoming and familial atmosphere to boost knowledge and hope for all who attend.


Renee Wegrzyn, Ph.D.

Director, Advanced Research Projects Agency for Health (ARPA-H)

Dr. Renee Wegrzyn serves as the first director of the Advanced Research Projects Agency for Health (ARPA-H), appointed on Oct. 11, 2022, by President Joseph R. Biden.


Previously, Wegrzyn served as a vice president of business development at Ginkgo Bioworks and head of innovation at Concentric by Ginkgo, where she focused on applying synthetic biology to outpace infectious diseases – including COVID-19 – through biomanufacturing, vaccine innovation, and biosurveillance of pathogens at scale.


Wegrzyn comes to ARPA-H with experience working for two of the institutions that inspired the creation of the agency – the Defense Advanced Research Projects Agency (DARPA) and Intelligence Advanced Research Projects Activity (IARPA).


As a Program Manager in the DARPA Biological Technologies Office, Wegrzyn leveraged the tools of synthetic biology and gene editing to enhance biosecurity, support the domestic bioeconomy, and thwart biothreats. Her DARPA portfolio included the Living Foundries: 1000 Molecules, Safe Genes; Preemptive Expression of Protective Alleles and Response Elements (PREPARE); and the Detect it with Gene Editing Technologies (DIGET) programs.


Wegrzyn received the Superior Public Service Medal for her work and contributions at DARPA. Prior to joining DARPA, she led technical teams in private industry in the areas of biosecurity, gene therapies, emerging infectious disease, neuromodulation, synthetic biology, as well as research and development teams commercializing multiplex immunoassays and peptide-based disease diagnostics.

Renee Wegrzyn - rectangle_portrait1 (1).png
One Mind Rising Star Awards Logo_transparent.png

The 2024 One Mind Rising Star Award winners will be at the Science & Innovation Symposium to present their awarded research projects and participate in a Q&A session with those in attendance. 

One Mind Accelerator Logo_All Black_Stacked.png

The One Mind Accelerator backs visionary founders of early-stage startups with the network, education, and capital to rapidly build category-defining companies that improve the lives of people living with mental illness.
The One Mind Accelerator was launched in 2023, with an inaugural cohort of 11 companies. This year, 10 startups were selected from 181 applications for the 2024 session. Each company will receive a  $100,000 investment from One Mind and will participate in 9 weeks of intensive programming designed to help founders rapidly take their companies to the next level.



Deep Science & Tech


with the 2024 One Mind Accelerator Startups

Innovation Spotlight Speakers have not yet been announced.

bottom of page